Company intelligence / Profile preview
Genexa
- Ownership
- Private
- Development stage
- Other
Overview
Genexa produces FDA-compliant, over-the-counter medicines using the same active ingredients as category leaders, but with 'clean' inactive ingredient profiles (no artificial dyes, preservatives, common allergens, or unnecessary fillers). They have established retail distribution nationwide and have patented a preservative system for greater ingredient transparency and safety. Clinical data for individual products is not disclosed, as efficacy is presumed equivalent to standard OTC based on use of the same actives and compliance with FDA monographs.
- Therapeutic areas
- Infectious DiseasesGastroenterologyNeurologyImmunology
- Modalities
- Small moleculeHomeopathic medicine
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Genexa.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genexa.